Financing Technology's Frontier and over one million other books are available for Amazon Kindle. Learn more

Have one to sell? Sell yours here
Financing Technology's Frontier: Decision-Making Models for Investors and Advisors
 
 
Start reading Financing Technology's Frontier on your Kindle in under a minute.

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Financing Technology's Frontier: Decision-Making Models for Investors and Advisors [Hardcover]

Richard P. Shanley (Author)
3.0 out of 5 stars  See all reviews (2 customer reviews)


Available from these sellers.


Textbook Student FREE Two-Day Shipping for Students. Learn more

Formats

Amazon Price New from Used from
Kindle Edition $63.96  
Hardcover $79.95  
Hardcover, June 30, 1998 --  
There is a newer edition of this item:
Financing Technology's Frontier: Decision-Making  Models for Investors and Advisors (Wiley Finance) Financing Technology's Frontier: Decision-Making Models for Investors and Advisors (Wiley Finance) 3.0 out of 5 stars (2)
$79.95
In Stock.

Book Description

0471168912 978-0471168911 June 30, 1998 1
The high-technology and biotechnology industries have experienced tremendous growth over the past two decades, fueled by investors eager to reap the large financial rewards these industries can provide. More recently, however, enthusiasm over these potential high returns is often tempered by reluctance to invest in innovative products and services whose research and development costs continue to rise and whose market value is still unproven. Technology companies find it difficult to obtain funding from a financial community that views such investment as alternately attractive and high risk.

Financing Technology's Frontier explores what it takes to finance companies at the cutting edge of technological innovation. In a concise and practical presentation, this book focuses on the technical issues surrounding financing for high-tech and biotech ventures, addressing those directly involved in the investment process: investors, financial and business advisors, and technology-based companies themselves.

Featuring numerous examples and case studies and including a wealth of financing information from a variety of sources, author Richard Shanley presents the point of view of investment bankers and venture capitalists, while also explaining the inner workings of the high-tech and biotech industries to investors. He draws on the real-world expertise of a group of directors and partners from well-known venture capital and investment banking firms, as well as several CEOs of successful technology companies.

Mr. Shanley describes business models that encourage investment, examines objectives and criteria used by investors when considering investing in a company, and suggests ways to find the right investor for a given company. He details a wide range of financial strategies -public and private, mainstream and alternative, and corporate partnerships, as well as tax planning strategies for cash conservation.

Financing Technology's Frontier equips investors and investment analysts with powerful decision-making tools, makes business and financial advisors aware of financing information crucial to their clients, and allows entrepreneurs, CEOs, and CFOs of high-tech and biotech companies to learn from the successes or setbacks of companies featured in the case studies. It is an important reference for anyone interested in the future of these rapidly evolving technology industries.

Financing strategies for companies at the cutting edge of technological innovation

The first book to fully explore what it takes to raise money for high-tech and biotech ventures in a volatile financial environment, Financing Technology's Frontier answers the most frequently asked questions concerning the investment process. Addressing investors, business and financial advisors, and entrepreneurs, this book provides information that is crucial to the success of any high-tech or biotech investment, including:
* How to obtain financing for increasingly expensive research and development, and how to stay afloat financially before commercializing a product
* What criteria venture capitalists and investment bankers employ when considering financing a company
* What makes a good match between investor and investment
* How to make the best investment decision for groundbreaking products or services with no track record in the marketplace
* And much more

Editorial Reviews

Review

& a wealth of illustrative examples & should kickstart some fruitful thinking. -- Internet Works, May 2004

“… a wealth of illustrative examples … should kickstart some fruitful thinking.” (Internet Works, May 2004) --This text refers to an alternate Hardcover edition.

From the Publisher

To fund increasingly expensive research and development, high-technology and biotechnology companies need to raise private or public money from a financial community that views them as immensely interesting yet also high risk. This book explores the subject of raising money to fund these industries and addresses the technical issues surrounding financing for those who need to know it the mostthe investors, the financial and business advisors, and the companies themselves. Provides investors with real-life examples and information that will help them make decisions.

Product Details

  • Hardcover: 216 pages
  • Publisher: Wiley; 1 edition (June 30, 1998)
  • Language: English
  • ISBN-10: 0471168912
  • ISBN-13: 978-0471168911
  • Product Dimensions: 9.9 x 6.3 x 0.8 inches
  • Shipping Weight: 1.1 pounds
  • Average Customer Review: 3.0 out of 5 stars  See all reviews (2 customer reviews)
  • Amazon Best Sellers Rank: #5,378,156 in Books (See Top 100 in Books)

More About the Author

Discover books, learn about writers, read author blogs, and more.

 

Customer Reviews

2 Reviews
5 star:
 (1)
4 star:    (0)
3 star:    (0)
2 star:    (0)
1 star:
 (1)
 
 
 
 
 
Average Customer Review
3.0 out of 5 stars (2 customer reviews)
 
 
 
 
Share your thoughts with other customers:
Most Helpful Customer Reviews

13 of 14 people found the following review helpful:
1.0 out of 5 stars Don't waste your $$$, November 21, 2000
By A Customer
This review is from: Financing Technology's Frontier: Decision-Making Models for Investors and Advisors (Hardcover)
Despite the nice title of the book, it is not worth a $105.00. The decision making models are overviews and are very brief. This book lacks numeracy. The case studies in my opinion are underdeveloped. The author spends time talking about strategic partnerships and the need for venture portfolio companies, to develop them, but he doesn't provide any examples of those that worked. There is some information to be gleaned from this book, but if you can get it for under $30, then buy it. Otherwise at $105, you will be very disappointed. This book is totally overpriced. If I could photocopy it and return it, I would have.
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


1 of 1 people found the following review helpful:
5.0 out of 5 stars Great, great business book..., February 18, 2004
By 
Covers financing from a variety of angles, with a number of different thought points I had not considered on the tax and workforce side. Liked the focus on biotech and pharma as well.
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No

Share your thoughts with other customers: Create your own review
 
 
 
Only search this product's reviews



Inside This Book (learn more)
First Sentence:
As mankind stands on the edge of a new millennium, it is interesting and informative to take a look backward and measure how far technology has advanced in the last thousand years, and understand why the pace of change has accelerated so rapidly in just the last 100 years. Read the first page
Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
intrinsic value method, milestone payments, fair value method, drug discovery technologies, business commences, total cash outflow, corporate partner, emerging company, partnering strategy, partnering agreement, grant date, partnering arrangement
Key Phrases - Capitalized Phrases (CAPs): (learn more)
Human Genome Sciences, Cadus Pharmaceutical Corporation, Spring Street Brewing, Bristol-Myers Squibb, Magainin Pharmaceuticals, Mpath Interactive, Solvay Duphar, Total Entertainment Network, United States, Beecham Corporation, Jack Nelson, Small Business Administration, United Kingdom, Wit Capital, Financing the Future, Genetics Institute, Hartman General Partner, Investment Corporation, Sphinx Pharmaceuticals, Annual Report, Awards Number Dollars, Caprius Inc, Find Capital, Historical Sector Overview, Mpath Foundation
New!
Books on Related Topics | Concordance | Text Stats
Browse Sample Pages:
Front Cover | Front Flap | Table of Contents | First Pages | Index | Back Flap | Back Cover | Surprise Me!
Search Inside This Book:

Citations (learn more)
This book cites 5 books:



Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums


Listmania!


Create a Listmania! list

So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject